Polaryx Therapeutics, Inc. (PLYX)Healthcare | Biotechnology | Paramus, United States | NasdaqCM
6.12 USD
-0.27
(-4.225%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 6.32 +0.20 (3.306%) ⇧ (April 17, 2026, 7:34 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 1:14 p.m. EDT
PLYX exhibits significant volatility with a recent price dip to $5.68, but there are signs of potential momentum with recent price fluctuations. However, the stock is currently in a bearish trend, and the lack of dividend history makes it unsuitable for dividend-focused investors. The short-term forecasting model suggests no clear direction, indicating uncertainty in the near term. Long-term investors should be cautious due to the company's negative earnings and high price-to-book ratio, which may signal overvaluation. Overall, PLYX is not a strong candidate for either short-term or long-term investment at this time. |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 289,740,960 |
| Website | https://polaryx.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.82514286 |
| Address1 | South Tower |
| Address2 | 140 E Ridgewood Avenue Suite 415 |
| All Time High | 48.91 |
| All Time Low | 2.2 |
| Ask | 7.76 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 156,530 |
| Average Daily Volume3 Month | 2,101,179 |
| Average Volume | 2,101,179 |
| Average Volume10Days | 156,530 |
| Bid | 4.9 |
| Bid Size | 2 |
| Book Value | 0.096 |
| City | Paramus |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 6.12 |
| Current Ratio | 8.545 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 6.93 |
| Day Low | 5.91 |
| Display Name | Polaryx Therapeutics |
| Ebitda Margins | 0.0 |
| Enterprise Value | 284,597,984 |
| Eps Trailing Twelve Months | -0.19 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 5.1964 |
| Fifty Day Average Change | 0.9235997 |
| Fifty Day Average Change Percent | 0.17773837 |
| Fifty Two Week Change Percent | -82.51428 |
| Fifty Two Week High | 48.91 |
| Fifty Two Week High Change | -42.79 |
| Fifty Two Week High Change Percent | -0.8748722 |
| Fifty Two Week Low | 2.2 |
| Fifty Two Week Low Change | 3.9199998 |
| Fifty Two Week Low Change Percent | 1.781818 |
| Fifty Two Week Range | 2.2 - 48.91 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,770,042,600,000 |
| Float Shares | 4,983,355 |
| Free Cashflow | 505,875 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 2 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.73007005 |
| Held Percent Institutions | 0.0 |
| Implied Shares Outstanding | 47,343,297 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,026-02-02 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Polaryx Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage disorders in the United States. Its pipeline includes PLX-100, a preclinical stage orally administrable combination therapy; PLX-200, a repurposed oral small molecule for the treatment of LSDs; PLX-300, a preclinical stage orally administrable combination therapy; and PLX-400, a preclinical stage novel gene therapy candidate. The company was founded in 2014 and is based in Paramus, New Jersey. |
| Long Name | Polaryx Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 289,740,960 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_414729746 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -8,985,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 289,267,544 |
| Number Of Analyst Opinions | 1 |
| Open | 6.525 |
| Operating Cashflow | -3,944,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 201 940 7236 |
| Post Market Change | 0.20230007 |
| Post Market Change Percent | 3.3055568 |
| Post Market Price | 6.3223 |
| Post Market Time | 1,776,468,876 |
| Previous Close | 6.39 |
| Price Hint | 2 |
| Price To Book | 63.75 |
| Profit Margins | 0.0 |
| Quick Ratio | 8.501 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.27 |
| Regular Market Change Percent | -4.22535 |
| Regular Market Day High | 6.93 |
| Regular Market Day Low | 5.91 |
| Regular Market Day Range | 5.91 - 6.93 |
| Regular Market Open | 6.525 |
| Regular Market Previous Close | 6.39 |
| Regular Market Price | 6.12 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 84,912 |
| Return On Assets | -0.96119004 |
| Return On Equity | -1.93705 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 47,343,297 |
| Shares Percent Shares Out | 0.0083 |
| Shares Short | 393,306 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 217,092 |
| Short Name | Polaryx Therapeutics, Inc. |
| Short Percent Of Float | 0.020599999 |
| Short Ratio | 0.18 |
| Source Interval | 15 |
| State | NJ |
| Symbol | PLYX |
| Target High Price | 10.0 |
| Target Low Price | 10.0 |
| Target Mean Price | 10.0 |
| Target Median Price | 10.0 |
| Total Cash | 5,143,000 |
| Total Cash Per Share | 0.109 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.19 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 6.401321 |
| Two Hundred Day Average Change | -0.28132105 |
| Two Hundred Day Average Change Percent | -0.043947343 |
| Type Disp | Equity |
| Volume | 84,912 |
| Website | https://polaryx.com |
| Zip | 7,652 |